Comparative Adherence Trajectories of Oral Fingolimod and Injectable Disease Modifying Agents in Multiple Sclerosis
Jagadeswara R Earla,1 George J Hutton,2 J Douglas Thornton,1 Hua Chen,1 Michael L Johnson,1 Rajender R Aparasu1 1Pharmaceutical Health Outcomes and Policy, College of Pharmacy, University of Houston, Houston, TX, USA; 2Department of Neurology, Baylor College of Medicine, Houston, TX, USACorresponden...
Main Authors: | Earla JR, Hutton GJ, Thornton JD, Chen H, Johnson ML, Aparasu RR |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-11-01
|
Series: | Patient Preference and Adherence |
Subjects: | |
Online Access: | https://www.dovepress.com/comparative-adherence-trajectories-of-oral-fingolimod-and-injectable-d-peer-reviewed-article-PPA |
Similar Items
-
Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study
by: Zimmer A, et al.
Published: (2017-10-01) -
Adherence to fingolimod in multiple sclerosis: an investigator-initiated, prospective, observational, single-center cohort study
by: Zimmer, Andrea, et al.
Published: (2017) -
Design and Implementation of a Direct Memory Access Controller for Embedded Applications
by: Mohammed Altaf Ahmed, et al.
Published: (2019-04-01) -
Effect of fingolimod on platelet count among multiple sclerosis patients
by: Mehrdad Farrokhi, et al.
Published: (2015-01-01) -
Injectable disease modifying agents in multiple sclerosis: pattern of medication use and clinical effectiveness
by: Elina Järvinen, et al.
Published: (2016-09-01)